A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis

NCT03010527 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

217

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Plaque Psoriasis

Interventions

DRUG: Bimekizumab
OTHER: Placebo

Sponsor

UCB Biopharma SRL